Johnson Johnson Aktie
138,48
EUR
+0,96
EUR
+0,70
%
156,22
USD
+0,10
USD
+0,06
%
nachbörslich
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Kursziele der Johnson Johnson-Aktie in
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Werbung
Kursziele im Branchenvergleich
Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
---|---|---|---|---|---|
Abbott Laboratories | 0 | 0 | 0 | - | - |
Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
Allergan Inc. | 0 | 0 | 0 | - | - |
APONTIS PHARMA | 0 | 0 | 0 | - | - |
AstraZeneca PLC | 6 | 3 | 0 | 136,60 GBP | +27,02% |
Bayer | 1 | 8 | 0 | 25,03 EUR | +4,75% |
Beiersdorf AG | 8 | 1 | 2 | 144,20 EUR | +14,99% |
BioNTech (ADRs) | 4 | 2 | 0 | 131,67 USD | +25,47% |
CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
Celgene Corp. | 0 | 0 | 0 | - | - |
CureVac | 0 | 1 | 0 | - | - |
Douglas | 3 | 1 | 0 | 18,12 EUR | +69,66% |
Fresenius Medical Care (FMC) St. | 3 | 5 | 2 | 45,28 EUR | -0,26% |
Fresenius SE & Co. KGaA (St.) | 8 | 2 | 0 | 47,77 EUR | +12,67% |
GSK PLC Registered Shs | 2 | 5 | 1 | 16,31 GBP | +12,60% |
Johnson & Johnson | 0 | 0 | 0 | - | - |
Merck Co. | 0 | 0 | 0 | - | - |
Merck KGaA | 7 | 1 | 0 | 179,43 EUR | +43,72% |
Moderna Inc | 0 | 2 | 1 | 67,33 USD | +143,86% |
MorphoSys | 0 | 1 | 0 | 68,00 EUR | - |
Nestlé SA (Nestle) | 3 | 7 | 1 | 85,30 CHF | -2,63% |
Novartis AG | 3 | 5 | 1 | 99,75 CHF | +5,88% |
Novavax Inc. | 0 | 0 | 0 | - | - |
Pfizer Inc. | 3 | 3 | 0 | 29,20 USD | +20,66% |
Procter & Gamble Co. | 1 | 0 | 0 | 177,00 USD | +10,27% |
Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
Sanofi S.A. | 6 | 3 | 0 | 115,12 EUR | +17,59% |
Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
STADA | 0 | 0 | 0 | - | - |
Unilever plc | 6 | 1 | 3 | 48,00 GBP | - |
Valneva | 0 | 0 | 0 | - | - |